Silicon Laboratories (NASDAQ:SLAB - Get Free Report) is anticipated to release its Q2 2025 earnings data before the market opens on Wednesday, July 23rd. Analysts expect Silicon Laboratories to post earnings of $0.09 per share and revenue of $192.57 million for the quarter. Silicon Laboratories has set its Q2 2025 guidance at -0.010-0.190 EPS.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its earnings results on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.01. The company had revenue of $177.71 million during the quarter, compared to analysts' expectations of $177.48 million. Silicon Laboratories had a negative net margin of 25.16% and a negative return on equity of 8.80%. Silicon Laboratories's quarterly revenue was up 67.0% on a year-over-year basis. During the same period last year, the company posted ($0.92) earnings per share. On average, analysts expect Silicon Laboratories to post $-1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Silicon Laboratories Stock Up 2.9%
SLAB stock traded up $4.24 during mid-day trading on Friday, hitting $149.63. The company had a trading volume of 559,620 shares, compared to its average volume of 354,233. The company has a 50-day moving average price of $136.58 and a 200 day moving average price of $127.89. Silicon Laboratories has a 12-month low of $82.82 and a 12-month high of $160.00. The company has a market capitalization of $4.87 billion, a price-to-earnings ratio of -29.28 and a beta of 1.47.
Insiders Place Their Bets
In related news, SVP Robert J. Conrad sold 4,029 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $131.20, for a total transaction of $528,604.80. Following the completion of the sale, the senior vice president directly owned 25,380 shares of the company's stock, valued at approximately $3,329,856. This trade represents a 13.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Robert Matthew Johnson sold 5,879 shares of the company's stock in a transaction on Friday, May 16th. The shares were sold at an average price of $131.20, for a total value of $771,324.80. Following the completion of the transaction, the chief executive officer directly owned 73,688 shares in the company, valued at $9,667,865.60. This trade represents a 7.39% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 11,626 shares of company stock valued at $1,509,319 over the last 90 days. Insiders own 1.60% of the company's stock.
Institutional Investors Weigh In On Silicon Laboratories
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Jane Street Group LLC raised its stake in shares of Silicon Laboratories by 329.2% during the first quarter. Jane Street Group LLC now owns 75,397 shares of the semiconductor company's stock valued at $8,487,000 after acquiring an additional 57,829 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Silicon Laboratories by 1.8% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 97,156 shares of the semiconductor company's stock worth $10,937,000 after purchasing an additional 1,679 shares during the period. United Services Automobile Association bought a new stake in Silicon Laboratories during the 1st quarter valued at $235,000. Jones Financial Companies Lllp lifted its holdings in shares of Silicon Laboratories by 121.4% in the 1st quarter. Jones Financial Companies Lllp now owns 496 shares of the semiconductor company's stock worth $56,000 after buying an additional 272 shares during the period. Finally, Millennium Management LLC lifted its holdings in shares of Silicon Laboratories by 2,804.1% in the 1st quarter. Millennium Management LLC now owns 99,842 shares of the semiconductor company's stock worth $11,239,000 after buying an additional 96,404 shares during the period.
Wall Street Analyst Weigh In
A number of research firms have issued reports on SLAB. Barclays reduced their price objective on Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating on the stock in a research note on Tuesday, April 22nd. Needham & Company LLC reaffirmed a "buy" rating and set a $150.00 price target on shares of Silicon Laboratories in a research note on Wednesday, May 14th. Benchmark reiterated a "buy" rating and set a $160.00 price objective on shares of Silicon Laboratories in a research report on Tuesday, May 27th. Stifel Nicolaus boosted their target price on shares of Silicon Laboratories from $144.00 to $160.00 and gave the stock a "buy" rating in a report on Friday. Finally, Susquehanna increased their price target on shares of Silicon Laboratories from $100.00 to $110.00 and gave the company a "neutral" rating in a report on Wednesday, May 14th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $134.00.
Read Our Latest Stock Report on Silicon Laboratories
About Silicon Laboratories
(
Get Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Recommended Stories

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report